22.Jan.2021 DD DSS (Document Security Systems Inc.)
Website: DSS - Document Security Systems
Document Security Systems a multinational company operating businesses focused on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets.
Market Cap: 24M
Free Float: 3.8M
Beaten-down micro-cap
Buy the Managment
Recent NEWS:
The first tranche of the two-part special share dividend was announced in August 2020. The Bonus Shares are expected to be issued after an IPO of Impact BioMedical, which the Company is targeting in 2021.
Link: DSS Reiterates Plans for Impact BioMedical Share Dividend
Expected NEWS:
IPO of Impact BioMedical, which the Company is targeting in 2021
Link: DSS Reiterates Plans for Impact BioMedical Share Dividend
--------------------------------------------------------------------------------------------------------------------------
ALSET owns 19.9% of DSS Shares
Website: Alset International Limited
1. Alternative Forms of Medical Drugs and Treatment Options.
2. Innovative Health Foods and Beverages.
3. Information and Communications Technology (ICT), E-Commerce, Blockchain and Security Technologies.
4. Smart and Sustainable Homes to Cultivate a Healthy Living Lifestyle.
--------------------------------------------------------------------------------------------------------------------------
DSS owns 32.2% of Sharing Services (OTC: SHRG)
Website: Sharing Services Global Corporation
MISSION To revolutionize the model in the direct selling industry by creating a diversified holdings company that maintains an ownership interest in several direct selling companies and creating a “Blue Ocean Strategy.”
VISION Create a “Blue Ocean Strategy,” which melds certain key components together to implement the company’s mission. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” (an Elevated Entrepreneur), utilizing the direct selling channel to generate 100 % organic growth, and creating as many successful independent business leaders as possible.
-----------------------------------------------------------------------------------------------------------------------------
DSS Executive Chairman Mr. CHAN HENG FAI
Website: Chan Heng Fai
-----------------------------------------------------------------------------------------------------------------------------
DSS Subsidary AMRE (American Medical REIT)
Website: American Medical REIT Inc.
Imapact Biomedical
Website: Impact Biomedical
1st Remember:
DSS shareholders earned a bonus of two shares of Impact BioMedical for every one share of DSS common stock held.
2nd Remember:
IPO of Impact BioMedical, which the Company is targeting in 2021.
DSS entered into a 10-year exclusive distribution agreement with Impact BioMed Technology.
BioMed manufacturing natural probiotics, pursuant to which the Company will directly market, advertise, promote, distribute and sell certain BioMed products to resellers.
Distribution Agreement, the Company will have exclusive rights to distribute the products within the United States, Canada, Singapore, Malaysia, and South Korea and non-exclusive distribution rights in all other countries.
Product Pipeline:
1. 3F (Functional Fragrance Formulation) is a unique formulation of specialized ingredients (e.g. terpenes) from botanical sources with demonstrated effect as an insect repellent and an antimicrobial. 3F Mosquito Repellent / 3F Antimicrobial to kill viruses.
2. Equivir/Nemovir technology is a novel blend of FDA Generally Recognized as Safe (GRAS) eligible polyphenols (e.g. Myricetin, Hesperetin, Piperine) which have demonstrated antiviral effects with
additional potential application as health supplements or medication. Polyphenols are sourced from fruits, vegetables, and other natural substances.
3. Natural polyphenols have demonstrated strong potential in treating and preventing a range of diseases by inhibiting TNF- and indication specific causes (e.g. neurology, anti-inflammatory, oncology).
Comments
Post a Comment